Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) was down 0.2% on Thursday . The company traded as low as $791.50 and last ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Eli Lilly has surpassed that S&P 500 five years in a row when Wall Street recognized its enormous opportunity in obesity ...

During FDA-declared shortages, pharmacists can legally make compounded versions of brand-name medications. But drugmakers and some health experts have pushed back against the practice because the FDA ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

2024’s progress hints at things to come. Clark took the WNBA—and basketball—to a new level Banga is tasked with helping find funds for emissions reduction and climate change adaptation ...

The president-elect made the announcement on Truth Social on Sunday. ABC News’ MaryAlice Parks discusses President Joe Biden's invitation for President-elect Donald Trump to visit the White ...

Airports are warning of delays for both departing and arriving flights as thick fog continues around the country. Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus ...